July 24, 2026
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreApril 21, 2026
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreJuly 09, 2026
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreAugust 06, 2026
Peptide Therapeutics Market(By Type: Branded Peptide Drugs, Generic Peptide Drugs, By Route of Administration: Parenteral, Oral, Transdermal & Others, By Application/Therapeutic: Area Oncology, Metabolic Disorders, Infectious Diseases, Cardiovascular Disorders, Neurological Disorders, Others; By Synthesis Technology: Solid Phase Peptide Synt...
August 06, 2026
According to Payal Rabde, who specializes in the diagnosis and evaluation of sciatica, pain management with medications, and physical therapy and rehabilitation programs, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the sciatica treatment market. The global sciatic...
August 06, 2026
According to Payal Rabde, who specializes in targeted therapies for head and neck cancers, immunotherapy treatments, including immune checkpoint inhibitors, and chemotherapy drugs and combination therapies, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the head &...
August 06, 2026
According to Payal Rabde, who specializes in digital pathology image analysis, AI-powered cancer diagnosis, and biomarker detection and qualification, with 4+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the antithrombin market. The global antithrombin market size was esti...
August 06, 2026
Cell and Gene Therapy for Oncology Market (By Therapy Type: Cell Therapy, Gene Therapy, Non-Viral Gene Therapy, Gene Editing Therapy; By Cancer Type: Hematological Malignancies, Solid Tumors; By Therapy Source: Autologous Therapies, Allogeneic Therapies; By Delivery Vector: Viral Vectors; By Application: Therapeutic Application, Research Applicatio...
August 06, 2026
According to Rohan Patil, who specializes in therapeutic areas, biopharmaceuticals, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the U.S. vaccines market. The U.S. vaccines market size was estimated at USD 38.24 billion in 2025 a...
August 06, 2026
According to Payal Rabde, who specializes in ophthalmic diseases, advanced therapies, and healthcare market intelligence, with 5+ years of experience in market research and industry analysis, extensive research indicates strong growth opportunities in the dry age-related macular degeneration market. The global dry age-related macular degenera...
August 05, 2026
According to market projections, the ulcerative colitis treatment sector is expected to grow from USD 11.46 billion in 2026 to USD 16.45 billion by 2035, reflecting a CAGR of 4.1%. The battle against ulcerative colitis is heating up! Pancolitis, the most widespread form, accounted for 34% of cases in 2023. Anti-TNF biologics lead treatment options ...
August 05, 2026
Market insights predict the global nanomedicine industry will increase from USD 241.49 billion in 2026 to USD 695.92 billion by 2035, achieving a CAGR of 10.1%. In 2025, North America led the market, while Asia-Pacific is the fastest-growing region. Drug delivery dominated by application, but therapeutics is set for rapid growth. Clinical oncology ...
August 05, 2026
Based on market forecasts, the alzheimer’s therapeutics sector will expand from USD 5.7 billion in 2025 to USD 13.13 billion by 2035, experiencing a CAGR of 8.7%. In 2025, North America led the market, while Asia-Pacific is set for the fastest growth ahead. Cholinesterase inhibitors dominated by product, but pipeline drugs are expected to gro...